XML 85 R72.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY - Textuals (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Mar. 31, 2022
Jan. 31, 2020
Stockholders Equity [Line Items]          
Aggregate number of shares authorized for repurchase       10,000,000  
Stock repurchase program, remaining shares authorized 8,412,419        
Common stock share acquired 1,587,581 656,213 0    
Aggregate purchase price $ 26,949 $ 17,300      
Granted 0 0 0    
Proceeds from exercise of equity awards     $ 297    
Stock options outstanding 0 10,000 18,245   39,311
Long-Term Incentive Stock Plan          
Stockholders Equity [Line Items]          
Shares available for grant 2,214,053        
Restricted Stock Units (RSUs)          
Stockholders Equity [Line Items]          
Vesting and exercise period of awards 3 years        
Restricted Stock Units (RSUs) | Long-Term Incentive Stock Plan          
Stockholders Equity [Line Items]          
Vesting and exercise period of awards 3 years        
Share-based compensation expense $ 32,500 $ 17,400 $ 6,100    
Unrecognized stock compensation related to unvested option awards 20,800 21,200 12,900    
Fair value of award for which restrictions lapsed $ 20,400 10,800 5,000    
Performance Shares [Member]          
Stockholders Equity [Line Items]          
Vesting and exercise period of awards 3 years        
Lock up period after vesting 2 years        
Performance Shares [Member] | Minimum          
Stockholders Equity [Line Items]          
Vesting and exercise period of awards 2 years        
Performance Shares [Member] | Maximum          
Stockholders Equity [Line Items]          
Vesting and exercise period of awards 5 years        
Stock Options          
Stockholders Equity [Line Items]          
Proceeds from exercise of equity awards $ 0 0      
Share-based compensation expense $ 0 $ 0 $ 100